New vaccine support (NVS) for YF
GAVI’s support for new vaccines presents an opportunity for countries to not only implement vaccines that protect against diseases causing substantial morbidity and/or mortality, but also to build upon the vaccine investments in order to increase immunisation coverage rates, and strengthen routine immunisation services and primary health care systems. WHO recommends that all GAVI-eligible countries at risk of yellow fever incorporate yellow fever vaccines into their national immunisation programmes. Countries at higher risk that have not to date introduced the vaccine into EPI (five of 32 GAVI-eligible countries in Africa) are encouraged to apply for GAVI support. This includes: Ethiopia, Mauritania, Sudan, South Sudan and Uganda.
- ID Projet
47122-0715-LBR-06B-X- Statut de l'activité
- 3 - Completion
- Type d'aide
- B02 - Contributions aux budgets réguliers des institutions multilatérales
- % to Libéria
- 100.00
Organisations
- Funding
- The Global Alliance for Vaccination and Immunisation
- Extending
- World Health Organisation - core voluntary contributions account (for technical assitance)
- Accountable
- Federal States & Local Governments
- Implementing
- Federal States & Local Governments
- Extending
- United Nations Childrens Fund
Versements par exercice fiscal, trimestre
| Exercice fiscal |
Trimestre fiscal |
Montant (USD) |
Libéria Montant (USD) |
| 2015 |
Q4 |
-4,751.00 |
-4,751.00 |
| 2015 |
Q2 |
-9,222.00 |
-9,222.00 |
| 2015 |
Q1 |
43,505.00 |
43,505.00 |
| 2014 |
Q4 |
14,531.00 |
14,531.00 |
| 2014 |
Q3 |
192,969.00 |
192,969.00 |
| 2013 |
Q3 |
192,641.00 |
192,641.00 |
| 2013 |
Q2 |
9,061.00 |
9,061.00 |
| 2012 |
Q4 |
42,000.00 |
42,000.00 |
| 2012 |
Q3 |
124,724.00 |
124,724.00 |
| 2012 |
Q2 |
-22,864.00 |
-22,864.00 |
| 2011 |
Q2 |
225,178.00 |
225,178.00 |
| 2011 |
Q1 |
-16,083.00 |
-16,083.00 |
| 2010 |
Q2 |
105,654.00 |
105,654.00 |
| 2010 |
Q1 |
1,187.00 |
1,187.00 |
| 2009 |
Q2 |
161,757.00 |
161,757.00 |
| 2008 |
Q3 |
104,532.00 |
104,532.00 |
| 2008 |
Q2 |
101,516.00 |
101,516.00 |
| 2007 |
Q2 |
100,514.00 |
100,514.00 |
| 2007 |
Q1 |
-56.00 |
-56.00 |
| 2006 |
Q3 |
4,000.00 |
4,000.00 |
| 2006 |
Q2 |
113,781.00 |
113,781.00 |
Engagements par exercice fiscal, trimestre
| Exercice fiscal |
Trimestre fiscal |
Montant (USD) |
Libéria Montant (USD) |
| 2015 |
Q1 |
39,000.00 |
39,000.00 |
| 2014 |
Q2 |
179,000.00 |
179,000.00 |
| 2013 |
Q2 |
186,500.00 |
186,500.00 |
| 2012 |
Q2 |
100,071.00 |
100,071.00 |
| 2011 |
Q1 |
200,000.00 |
200,000.00 |
| 2010 |
Q2 |
-5,388.00 |
-5,388.00 |
| 2010 |
Q1 |
123,500.00 |
123,500.00 |
| 2009 |
Q2 |
-3,892.00 |
-3,892.00 |
| 2008 |
Q2 |
201,500.00 |
201,500.00 |
| 2007 |
Q2 |
218,000.00 |
218,000.00 |
| 2007 |
Q1 |
168,781.00 |
168,781.00 |
Projections de CDMT par exercice fiscal
| Exercice fiscal |
Montant (USD) |
Libéria Montant (USD) |
| 2015 |
111,000.00 |
111,000.00 |
| 2014 |
214,250.00 |
214,250.00 |
| 2013 |
202,250.00 |
202,250.00 |
| 2012 |
193,000.00 |
193,000.00 |
| 2011 |
183,750.00 |
183,750.00 |
| 2010 |
176,500.00 |
176,500.00 |
| 2009 |
170,250.00 |
170,250.00 |
| 2008 |
134,500.00 |
134,500.00 |
| 2007 |
109,890.50 |
109,890.50 |
| 2006 |
58,890.50 |
58,890.50 |
| Code CRS |
% |
|
Lutte contre les maladies infectieuses
(12250)
|
100.0
|